Cyclerion Therapeutics, Inc.
DEUTERATED sGC STIMULATORS

Last updated:

Abstract:

This invention relates to deuterated compounds of Formula I, and pharmaceutically acceptable salts thereof. ##STR00001## or a pharmaceutically acceptable salt thereof, wherein each of Y.sup.1, Y.sup.2, Y.sup.3, Y.sup.4, Y.sup.5a, Y.sup.5b, Y.sup.6, Y.sup.7, Y.sup.8, Y.sup.9, Y.sup.10, Y.sup.11a and Y.sup.11b is independently selected from hydrogen and deuterium, as well as pharmaceutical compositions, methods and uses thereof.

Status:
Application
Type:

Utility

Filling date:

14 Jul 2020

Issue date:

21 Jan 2021